Effect of postoperative radiotherapy on the functional result of implants placed during ablative surgery for oral cancer

2006 ◽  
Vol 35 (9) ◽  
pp. 803-808 ◽  
Author(s):  
R.H. Schepers ◽  
A.P. Slagter ◽  
J.H.A.M. Kaanders ◽  
F.J.A. van den Hoogen ◽  
M.A.W. Merkx
Head & Neck ◽  
2016 ◽  
Vol 38 (S1) ◽  
pp. E2103-E2111 ◽  
Author(s):  
Jan Willem Wetzels ◽  
Ron Koole ◽  
Gert J. Meijer ◽  
Anton F. J. de Haan ◽  
Matthias A. W. Merkx ◽  
...  

Health Care ◽  
2013 ◽  
Vol 1 (3) ◽  
pp. 89
Author(s):  
Mohamed Mahmoud ◽  
Tarek Souman ◽  
Mohamed Amin ◽  
Mona Aboelenin

2016 ◽  
Vol 27 (4) ◽  
pp. 1010-1011 ◽  
Author(s):  
Reza Tabrizi ◽  
Sepanta Hosseinpour ◽  
Fateme Taghizadeh

Author(s):  
Kalvis Pastars ◽  
Jānis Zariņš ◽  
Juris Tārs ◽  
Anna Ivanova ◽  
Andrejs Skaģers

Abstract Radial forearm flap is a gold standard for oral soft tissue defect reconstruction after tumour ablative surgery of oral cancer in advanced stages. The main disadvantage of this flap is donor site morbidity. The goal of our study was to show versatility of lateral arm flap in 34 cases with different oral defects that were reconstructed after tumour ablation, and to analyse complications and donor site morbidity. Thirty-four patients with advanced stage oral cancer (T3 and T4) underwent tumour ablation with or without suspicious lymph node removal and with immediate reconstruction of oral defect with lateral arm flap. Analysis of complications and donor sites morbidity was carried out. The Michigan Hand Outcome Questionnaire was used to evaluate functional and esthetical donor site outcome during at least one year follow up. Thirty-one patients had successful free flap surgery with uneventful post-surgery period. Flap loss due to vascularity problems was in one case (2.9%). The flap success rate was 97.1%. The donor site was closed primarily in all cases and healed uneventfully. The Michigan Hand Outcome Score was average 94.30%. The lateral arm is an excellent choice for oral reconstruction after ablative tumour surgery. It is versatile, safe and reliable for oral reconstruction with very good functional and aesthetical donor site outcome.


2010 ◽  
Vol 186 (9) ◽  
pp. 496-501 ◽  
Author(s):  
Tomasz Rutkowski ◽  
Andrzej Wygoda ◽  
Marcin Hutnik ◽  
Krzysztof Składowski ◽  
Jerzy Wydmański ◽  
...  

2017 ◽  
Vol 35 (31_suppl) ◽  
pp. 222-222 ◽  
Author(s):  
Ourania Nicolatou-Galitis ◽  
Amanda Psyrri

222 Background: Patients, who receive radiotherapy (RT) for head and neck cancer, develop chronic functional abnormalities and reduced mouth opening-trismus, surviving with reduced quality of life (QoL). We aimed to study trismus and QoL in patients with oral cancer, who received post-operative radiotherapy or chemoradiotherapy. Methods: Patients, who receive radiotherapy (RT) for head and neck cancer, develop chronic functional abnormalities and reduced mouth opening-trismus, surviving with reduced quality of life (QoL). We aimed to study trismus and QoL in patients with oral cancer, who received post-operative radiotherapy or chemoradiotherapy. Results: Mean RT dose was 64.3 Gray. Six patients received chemoradiotherapy. Severe mucositis, pain and xerostomia were recorded in 6 and 5 patients respectively. MMO was reduced in all patients. The mean MMO (34 mm) reached the level of trismus. The total number of symptoms increased from 3.1 to 6.3 in C-30 and from 3.1 to 8.8 per patient in the H/N35. Severe fatigue, pain, limitations at work, weakness, sad feelings, family problems, sleeping problems, anorexia, financial difficulties, tense/irritable, constipation, nausea, vomiting and depression were most often reported with C-30. Most patients reported poor to moderate quality of life. Severe oral, jaw and neck pain, swallowing problems, taste alterations, sticky saliva, dry mouth, coarseness, dental problems, feeling sick and reduced interest in life/sex were the most common symptoms reported with N/H35. Conclusions: The observed trismus, the 2- to 3-fold increase of symptoms and poorer quality of life highlighted the need for support of oral cancer patients, who receive postoperative radiotherapy or chemoradiotherapy. Reduced systemic health, financial difficulties and family problems could be some of the main reasons for the inadequate compliance of our patients to the study, as shown by others, too. The strength of our study was the homogeneous group of patients: all had oral squamous cell carcinoma and all received post-operative radiotherapy or chemoradiotherapy. The small number of patients represents a weakness.


Sign in / Sign up

Export Citation Format

Share Document